Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Patients´ Mental and Physical Health After Covid-19 Treated in ICU in Sweden

  • Read more about Patients´ Mental and Physical Health After Covid-19 Treated in ICU in Sweden

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

  • Read more about Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

  • Read more about Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia

  • Read more about Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia

MIST Versus M-MIST for the Treatment of Intrabony Defects

  • Read more about MIST Versus M-MIST for the Treatment of Intrabony Defects

Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition

  • Read more about Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Read more about A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

  • Read more about Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma

  • Read more about Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma

The Living With a Long-Term Condition Study

  • Read more about The Living With a Long-Term Condition Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Current page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA